Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Rolence Enterprise Co. , Ltd. · Predicate Candidate Screening
12 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
74 daysmedian FDA review time
127 days90th percentile
12clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K001719 | Q-LUX PLASMA 100 LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 2000-10-10 | 127 | 0 |
| K991865 | Q-LITE 75 LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 1999-07-20 | 49 | 0 |
| K991863 | CUTE-LITE I LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 1999-07-19 | 48 | 0 |
| K980793 | Q-LUXPRO V/Q-LUXPRO II LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 1998-05-15 | 74 | 0 |
| K980792 | CU-100A LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 1998-05-15 | 74 | 0 |
| K960364 | CU-200 LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 1996-04-15 | 81 | 0 |
| K960351 | Q-LUX LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 1996-04-15 | 81 | 0 |
| K953628 | PROPHY ANGLE | Rolence Enterprise Co. , Ltd. | 1995-09-29 | 60 | 0 |
| K952423 | CU-100RLC LIGHT CURE UNIT, DOCUMENT NO.A715676 | Rolence Enterprise Co. , Ltd. | 1995-06-22 | 30 | 0 |
| K942199 | CU-100R LIGHT CURE UNIT, DOCUMENT NO. A715676 | Rolence Enterprise Co. , Ltd. | 1994-06-02 | 28 | 0 |
| K942198 | CU-80 LIGHT CURE UNIT, DOCUMENT NO. A715676 | Rolence Enterprise Co. , Ltd. | 1994-05-27 | 22 | 0 |
| K924727 | 100 LIGHT CURE UNIT | Rolence Enterprise Co. , Ltd. | 1993-06-17 | 269 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda